Derya Tilki1,2, Felix Preisser3,4, Pierre Karakiewicz4, Shahrokh F Shariat5, Markus Graefen3, Hartwig Huland3, Felix K Chun6, Raisa S Pompe3,4. 1. Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. dtilki@uke.de. 2. Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. dtilki@uke.de. 3. Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. 4. Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. 5. Department of Urology Medical, University of Vienna, Vienna, Austria. 6. Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Abstract
PURPOSE: To assess the impact of prolonged catheterization time on 1-week (short-term), 3-month (intermediate-term) and 1-year (long-term) UC. METHODS: Between 2008 and 2015, 6918 men underwent RP by four high-volume surgeons. Exclusion criteria were baseline urinary incontinence (UI) and radiotherapy prior or within 12 months after RP. For the remaining 4111 patients, data on short-, intermediate- and long-term UC were available for 3989, 2490 and 1967 patients, respectively. UC was defined as the use of zero or 1-safety pad/24 h. Time to catheter removal was categorized into ≤ 7, 8-14 and ≥ 15 days. To assess the impact of catheterization time on short-, intermediate- and long-term UI, uni- and multivariable logistic regression analyses adjusted for age, BMI, prostate volume, pathological tumor stage, Charlson comorbidity index and nerve-sparing technique were performed. RESULTS: Post-RP UC rates at 1 week for catheterization of ≤ 7, 8-14 and ≥ 15 days were 31.2, 27.4 and 18.0%. For the same groups, 3-month and 1-year UC rates were 82.7, 79.2 and 74.1% as well as 90.8, 91.6 and 88.2%, respectively. In multivariate logistic regressions, longer catheterization time was associated with worse short- and intermediate UI (OR 15 days: 2.19 and 1.54; p = ≤ 0.001 and p = 0.04). This difference dissipated at 1 year after RP (p > 0.05). CONCLUSIONS: While longer catheterization is associated with worse short- and intermediate-term UC, it has no adverse impact on long-term UC.
PURPOSE: To assess the impact of prolonged catheterization time on 1-week (short-term), 3-month (intermediate-term) and 1-year (long-term) UC. METHODS: Between 2008 and 2015, 6918 men underwent RP by four high-volume surgeons. Exclusion criteria were baseline urinary incontinence (UI) and radiotherapy prior or within 12 months after RP. For the remaining 4111 patients, data on short-, intermediate- and long-term UC were available for 3989, 2490 and 1967 patients, respectively. UC was defined as the use of zero or 1-safety pad/24 h. Time to catheter removal was categorized into ≤ 7, 8-14 and ≥ 15 days. To assess the impact of catheterization time on short-, intermediate- and long-term UI, uni- and multivariable logistic regression analyses adjusted for age, BMI, prostate volume, pathological tumor stage, Charlson comorbidity index and nerve-sparing technique were performed. RESULTS: Post-RP UC rates at 1 week for catheterization of ≤ 7, 8-14 and ≥ 15 days were 31.2, 27.4 and 18.0%. For the same groups, 3-month and 1-year UC rates were 82.7, 79.2 and 74.1% as well as 90.8, 91.6 and 88.2%, respectively. In multivariate logistic regressions, longer catheterization time was associated with worse short- and intermediate UI (OR 15 days: 2.19 and 1.54; p = ≤ 0.001 and p = 0.04). This difference dissipated at 1 year after RP (p > 0.05). CONCLUSIONS: While longer catheterization is associated with worse short- and intermediate-term UC, it has no adverse impact on long-term UC.
Authors: Vincenzo Ficarra; Giacomo Novara; Raymond C Rosen; Walter Artibani; Peter R Carroll; Anthony Costello; Mani Menon; Francesco Montorsi; Vipul R Patel; Jens-Uwe Stolzenburg; Henk Van der Poel; Timothy G Wilson; Filiberto Zattoni; Alexandre Mottrie Journal: Eur Urol Date: 2012-06-01 Impact factor: 20.096
Authors: A Nadu; L Salomon; A Hoznek; L E Olsson; F Saint; A de La Taille; A Cicco; D Chopin; C C Abbou Journal: J Urol Date: 2001-11 Impact factor: 7.450
Authors: Christian Gratzke; Zach Dovey; Giacomo Novara; Nicolas Geurts; Ruben De Groote; Peter Schatteman; Geert de Naeyer; Giorgio Gandaglia; Alexandre Mottrie Journal: Eur Urol Date: 2015-11-11 Impact factor: 20.096
Authors: Lars Budäus; Hendrik Isbarn; Thorsten Schlomm; Hans Heinzer; Alexander Haese; Thomas Steuber; Georg Salomon; Hartwig Huland; Markus Graefen Journal: Eur Urol Date: 2009-05-29 Impact factor: 20.096
Authors: Luigi Cormio; Giuseppe Di Fino; Carmen Scavone; Domenico Maroscia; Vito Mancini; Nicola Ruocco; Francesco Bellanti; Oscar Selvaggio; Francesca Sanguedolce; Giuseppe Lucarelli; Giuseppe Carrieri Journal: Medicine (Baltimore) Date: 2016-04 Impact factor: 1.889
Authors: Nina Natascha Harke; Christian Wagner; Nikolaos Liakos; Katarina Urbanova; Mustapha Addali; Boris A Hadaschik; Jorn H Witt Journal: World J Urol Date: 2020-05-02 Impact factor: 4.226
Authors: Sebastian Lenart; Ingrid Berger; Judith Böhler; Reinhard Böhm; Georg Gutjahr; Nikolaus Hartig; Daniel Koller; Michael Lamche; Stephan Madersbacher; Michael Stolzlechner; Claudia Elisa Wayand; Anton Ponholzer Journal: World J Urol Date: 2019-11-14 Impact factor: 4.226